🇺🇸 FDA
Pipeline program

Placebo

CAIN457K2340

Phase 3 mab completed

Quick answer

Placebo for Ankylosing Spondylitis is a Phase 3 program (mab) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Novartis Pharmaceuticals
Indication
Ankylosing Spondylitis
Phase
Phase 3
Modality
mab
Status
completed

Clinical trials